http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110564730-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-115 |
| filingDate | 2019-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110564730-B |
| titleOfInvention | A kind of CD40L nucleic acid aptamer and its application |
| abstract | The present invention relates to the field of biotechnology, in particular to a CD40L nucleic acid aptamer, the nucleic acid aptamer has the nucleotide sequence shown in (a) or (b); (a) SEQ ID NO: 1 or SEQ ID The nucleotide sequence shown in NO:2; or (b) truncation of 20 nucleotides each from the 5' end and the 3' end of the nucleotide sequence shown in SEQ ID NO:1 or SEQ ID NO:2 nucleotide sequence. The present invention also provides the application of the above-mentioned CD40L nucleic acid aptamer in detecting CD40L and the application in preparing a drug for suppressing immune response, and the present invention also provides a drug for suppressing immune response, including the above-mentioned CD40L nucleic acid aptamer and a pharmaceutically acceptable carrier or excipient. The CD40L nucleic acid aptamer of the present invention can specifically bind to CD40L, has high specificity, and has high affinity with CD40L. |
| priorityDate | 2019-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 103.